Drug discovery targeting bromodomain-containing protein 4
BRD4, the most extensively studied member of the BET family, is an epigenetic regulator
that localizes to DNA via binding to acetylated histones and controls the expression of …
that localizes to DNA via binding to acetylated histones and controls the expression of …
BRD4 in physiology and pathology:''BET''on its partners
Y Liang, J Tian, T Wu - Bioessays, 2021 - Wiley Online Library
Abstract Bromodomain‐containing 4 (BRD4), a member of Bromo and Extra‐Terminal (BET)
family, recognizes acetylated histones and is of importance in transcription, replication, and …
family, recognizes acetylated histones and is of importance in transcription, replication, and …
Novel strategies targeting bromodomain-containing protein 4 (BRD4) for cancer drug discovery
D Liang, Y Yu, Z Ma - European journal of medicinal chemistry, 2020 - Elsevier
As epigenetic readers of the histone code, BRD4 is the most extensively and thoroughly
studied member of BET family, which plays a critical role in many human diseases including …
studied member of BET family, which plays a critical role in many human diseases including …
Structure-guided design of potent diazobenzene inhibitors for the BET bromodomains
G Zhang, AN Plotnikov, E Rusinova… - Journal of medicinal …, 2013 - ACS Publications
BRD4, characterized by two acetyl-lysine binding bromodomains and an extra-terminal (ET)
domain, is a key chromatin organizer that directs gene activation in chromatin through …
domain, is a key chromatin organizer that directs gene activation in chromatin through …
A patent review of BRD4 inhibitors (2013-2019)
T Lu, W Lu, C Luo - Expert Opinion on Therapeutic Patents, 2020 - Taylor & Francis
Introduction: The bromodomain-containing protein 4 (BRD4), a member of the bromodomain
and extra-terminal (BET) family, functions as an 'epigenetic reader'that binds to acetylated …
and extra-terminal (BET) family, functions as an 'epigenetic reader'that binds to acetylated …
Bromodomain inhibitors and therapeutic applications
BK Gajjela, MM Zhou - Current opinion in chemical biology, 2023 - Elsevier
The bromodomain acts to recognize acetylated lysine in histones and transcription proteins
and plays a fundamental role in chromatin-based cellular processes including gene …
and plays a fundamental role in chromatin-based cellular processes including gene …
Dual‐target inhibitors of bromodomain and extra‐terminal proteins in cancer: A review from medicinal chemistry perspectives
L Feng, G Wang, Y Chen, G He, B Liu… - Medicinal research …, 2022 - Wiley Online Library
Abstract Bromodomain‐containing protein 4 (BRD4), as the most studied member of the
bromodomain and extra‐terminal (BET) family, is a chromatin reader protein interpreting …
bromodomain and extra‐terminal (BET) family, is a chromatin reader protein interpreting …
[HTML][HTML] Post-translational modifications of BRD4: therapeutic targets for tumor
N Liu, R Ling, X Tang, Y Yu, Y Zhou, D Chen - Frontiers in oncology, 2022 - frontiersin.org
Bromodomain-containing protein 4 (BRD4), a member of the bromodomain and
extraterminal (BET) family, is considered to be a major driver of cancer cell growth and a …
extraterminal (BET) family, is considered to be a major driver of cancer cell growth and a …
Targeting bromodomain and extraterminal proteins for drug discovery: from current progress to technological development
P Tang, J Zhang, J Liu, CM Chiang… - Journal of medicinal …, 2021 - ACS Publications
Bromodomain and extraterminal (BET) proteins bind acetylated lysine residues in histones
and nonhistone proteins via tandem bromodomains and regulate chromatin dynamics …
and nonhistone proteins via tandem bromodomains and regulate chromatin dynamics …
[HTML][HTML] The mechanisms behind the therapeutic activity of BET bromodomain inhibition
The bromodomain and extraterminal (BET) protein Brd4 recruits transcriptional regulatory
complexes to acetylated chromatin. While Brd4 is considered to be a general transcriptional …
complexes to acetylated chromatin. While Brd4 is considered to be a general transcriptional …